Medpace Holdings, Inc.
MEDPNASDAQHealthcareDiagnostics & Research
As of Oct 16, 2026 close
- Market cap
- $18.08B
- P/E (TTM)
- 36.78
- Forward P/E
- 31.67
- Dividend yield
- -
- 52-week range
- $373.00$677.90
- Volume (live)
- -
- Avg. volume (3M)
- 249.21K
Medpace Holdings (MEDP) Stock Price & Financial Analysis
Medpace Holdings Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $610.05 - $632.33 |
|---|---|
| 52-Week High | $677.90 |
| 52-Week Low | $373.00 |
| Open | $630.29 |
| Volume (last close) | 297.57K |
| Average Volume (3M) | 249.21K |
| Revenue (TTM) | 2.78B |
|---|---|
| Net Income (TTM) | 491.50M |
| Free Cash Flow (TTM) | 706.69M |
| EPS (TTM) | $16.89 |
| Profit Margin | 17.67% |
| Operating Margin | 20.97% |
| Return on Equity (ROE) | 113.29% |
| Debt to Equity | 0.28 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Payout Ratio | 0.00% |
| Market Cap | 18.08B |
|---|---|
| Shares Outstanding | 28.76M |
| P/E Ratio (TTM) | 36.78 |
| Forward P/E | 31.67 |
| Price to Sales (P/S) | 6.50 |
| Price to Book (P/B) | 41.67 |
| EV/EBITDA | 29.69 |
| 50-Day MA | $604.91 |
|---|---|
| 200-Day MA | $525.63 |
| 1-Year Change | +19.04% |
Source: Market prices and company fundamentals. Data as of Oct 16, 2026. Data sources and methodology
Medpace Holdings at a Glance
As of the Oct 16, 2026 close, Medpace Holdings (MEDP) has a market capitalization of $18.08B. The stock trades at 36.8× trailing earnings, 31.7× forward earnings and 6.5× sales. Over the trailing twelve months it earned $491.50M on revenue of $2.78B (a 17.7% profit margin) and generated $706.69M of free cash flow. Revenue grew 24.7% year over year.
As of its latest reported balance sheet, it holds $502.69M in cash and securities against $120.10M of debt, a net cash position of $382.59M.
Medpace Holdings does not currently pay a dividend.
The share price is up 19.0% over the past year. At $618.47 (the Oct 16, 2026 close) it sits within its 52-week range of $373.00 to $677.90, above its 200-day moving average of $525.63.
Based on 15 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $612.10, 1.0% below the Oct 16, 2026 close.
Frequently Asked Questions About Medpace Holdings
What is the current stock price for MEDP?
As of the Oct 16, 2026 close, MEDP stock trades at $618.47. The 52-week range is $373.00–$677.90, with a day range of $610.05–$632.33.
What is the P/E ratio for MEDP?
As of the Oct 16, 2026 close, Medpace Holdings's trailing twelve-month (TTM) P/E ratio is 36.8, meaning investors pay $36.8 for every $1 of annual earnings. The forward P/E is 31.7, reflecting analyst expectations for future earnings. Medpace Holdings operates in the Healthcare sector.
Does MEDP pay dividends?
Medpace Holdings does not currently pay a regular dividend. The company retains its earnings to reinvest in the business. Check the Dividends tab for historical dividend information.
What do analysts recommend for MEDP?
Based on ratings from 15 professional analysts over the last 90 days, the consensus for MEDP is Hold. The average 12-month price target is $612.10, a 1.0% downside from the Oct 16, 2026 close of $618.47.
What is the market cap of MEDP?
As of the Oct 16, 2026 close, Medpace Holdings's market capitalization is $17.79B, classifying it as a large-cap company. Medpace Holdings operates in the Healthcare sector within the Diagnostics & Research industry.